• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物相关的戒断综合征。

Withdrawal syndromes associated with antipsychotic drugs.

作者信息

Gardos G, Cole J O, Tarsy D

出版信息

Am J Psychiatry. 1978 Nov;135(11):1321-4. doi: 10.1176/ajp.135.11.1321.

DOI:10.1176/ajp.135.11.1321
PMID:30287
Abstract

Withdrawal symptoms frequently follow abrupt discontinuation of antipsychotic compounds. In addition to other somatic symptoms, withdrawal-emergent dyskinesias may be observed. "Covert dyskinesia" refers to a masked form of tardive dyskinesia that becomes clinically detectable only after antipsychotic drugs are withdrawn or their dosage is reduced. Withdrawal dyskinesia appears under similar circumstances but disappears spontaneously in 6 to 12 weeks. Cholinergic overactivity and changes in dopamine-acetylcholine balance in the basal ganglia may underlie these withdrawal syndromes. The principal value of the concept of covert dyskinesia is in the secondary and tertiary prevention of tardive dyskinesia through early discovery and treatment.

摘要

抗精神病药物突然停药后常出现戒断症状。除其他躯体症状外,还可能观察到戒断后出现的运动障碍。“隐性运动障碍”是指迟发性运动障碍的一种隐匿形式,仅在停用抗精神病药物或降低其剂量后才在临床上可检测到。戒断性运动障碍在类似情况下出现,但在6至12周内会自行消失。胆碱能活动过度以及基底神经节中多巴胺 - 乙酰胆碱平衡的变化可能是这些戒断综合征的基础。隐性运动障碍概念的主要价值在于通过早期发现和治疗对迟发性运动障碍进行二级和三级预防。

相似文献

1
Withdrawal syndromes associated with antipsychotic drugs.抗精神病药物相关的戒断综合征。
Am J Psychiatry. 1978 Nov;135(11):1321-4. doi: 10.1176/ajp.135.11.1321.
2
Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.抗精神病药物撤药后静坐不能与抗精神病药物所致静坐不能:迟发性静坐不能存在的进一步证据
J Clin Psychiatry. 1988 Nov;49(11):435-8.
3
Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.精神分裂症患者在停用抗精神病药物期间出现的撤药后运动障碍。
Biol Psychiatry. 1995 Dec 1;38(11):713-9. doi: 10.1016/0006-3223(95)00082-8.
4
Covert dyskinesia associated with aripiprazole: a case report and review of the literature.阿立哌唑相关的隐匿性运动障碍:一例报告及文献复习
Clin Neuropharmacol. 2013 Jul-Aug;36(4):128-30. doi: 10.1097/WNF.0b013e31829b99d9.
5
Treatment of tardive dyskinesia: use of dopamine-depleting agents.迟发性运动障碍的治疗:多巴胺耗竭剂的使用。
Clin Neuropharmacol. 1983 Jun;6(2):151-8. doi: 10.1097/00002826-198306000-00009.
6
[Therapeutic measures in tardive dyskinesia].[迟发性运动障碍的治疗措施]
Fortschr Neurol Psychiatr. 1983 Jun;51(6):203-26. doi: 10.1055/s-2007-1002227.
7
Tardive dyskinesia: side effect or not?迟发性运动障碍:是否为副作用?
Am J Psychiatry. 1973 Apr;130(4):406-10. doi: 10.1176/ajp.130.4.406.
8
Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.抗精神病药物所致超敏性精神病:对精神分裂症住院患者的回顾性研究。
J Clin Psychiatry. 1988 Jul;49(7):258-61.
9
The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.迟发性运动障碍、自发性运动障碍及其他肌张力障碍的神经药理学
J Clin Psychopharmacol. 1982 Oct;2(5):321-8.
10
Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.预防长期使用抗精神病药物的危害及避免不必要用药问题的方法。
Adv Biochem Psychopharmacol. 1980;24:505-11.

引用本文的文献

1
Withdrawal Dyskinesia Associated With Aripiprazole in a Child: A Case Report.儿童阿立哌唑所致撤药运动障碍:1例报告
Cureus. 2024 Jul 23;16(7):e65223. doi: 10.7759/cureus.65223. eCollection 2024 Jul.
2
Neuroleptic malignant syndrome after abrupt discontinuation of neuroleptic and anticholinergic drugs.停用抗精神病药物和抗胆碱能药物后出现的神经阻滞剂恶性综合征。
Ind Psychiatry J. 2023 Nov;32(Suppl 1):S277-S278. doi: 10.4103/ipj.ipj_207_23. Epub 2023 Nov 30.
3
Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis.
儿科人群中的抗精神病药物滥用、依赖和戒断:一项真实世界的不成比例分析。
Biomedicines. 2022 Nov 18;10(11):2972. doi: 10.3390/biomedicines10112972.
4
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.鉴别迟发性运动障碍:临床实践中基于视频的抗精神病药相关运动障碍综述。
CNS Spectr. 2022 Apr;27(2):208-217. doi: 10.1017/S109285292000200X. Epub 2020 Nov 20.
5
Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.老年人药物性帕金森综合征和迟发性运动障碍的当前治疗与预防方法
Drugs Aging. 2018 Nov;35(11):959-971. doi: 10.1007/s40266-018-0590-y.
6
Amisulpride withdrawal dyskinesia: a case report.氨磺必利撤药后运动障碍:一例报告
Ann Gen Psychiatry. 2017 Jun 14;16:25. doi: 10.1186/s12991-017-0148-0. eCollection 2017.
7
Covert Dyskinesia With Aripiprazole: A Case Report.阿立哌唑所致隐匿性运动障碍:一例报告
Prim Care Companion CNS Disord. 2016 Jun 9;18(3). doi: 10.4088/PCC.15l01889. eCollection 2016.
8
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.母亲接触处方药后的新生儿适应问题:戒断综合征和残留药理作用。
Drug Saf. 2016 Oct;39(10):903-24. doi: 10.1007/s40264-016-0435-8.
9
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.精神分裂症中多巴胺D2受体及相关受体相互作用蛋白的改变:多巴胺超敏性精神病在难治性精神分裂症中的关键地位
Int J Mol Sci. 2015 Dec 17;16(12):30144-63. doi: 10.3390/ijms161226228.
10
Abnormal involuntary movements: side-effect of neuroleptic drugs.异常不自主运动:神经安定药物的副作用。
Can Fam Physician. 1982 Jan;28:105-9.